Cardiovascular Risk in Type 2 Diabetes

Cardiovascular disease (CVD) is a major complication of diabetes and a leading cause of morbidity and mortality worldwide. Diabetes mellitus is a chronic condition that occurs either the body cannot produce enough or produced insulin that the body does not use properly. Comparisons of people without diabetes, people with type 2 diabetes mellitus have a considerably higher risk of cardiovascular morbidity and mortality and are excessively affected by cardiovascular disease. Most of this excess risk is associated with better prevalence of well-known risk factors such as hypertension, dyslipidemia and obesity. For medication, such as statins and blood pressure-lowering agents, may be necessary for some individuals. Recent advances in personalized medicine and Regular approaches of healthcare providers are crucial for effective management and prevention of CVD.

  • Hypertension
  • Dyslipidemia
  • Obesity
  • Insulin resistance and Hyperglycemia
  • Microvascular complications

 


 


    Related Conference of Cardiovascular Risk in Type 2 Diabetes

    September 09-10, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    September 25-26, 2024

    5th World Summit on Diabetes Expo

    Rome, Italy
    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands

    Cardiovascular Risk in Type 2 Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in